The kinase inhibitor field is maturing.

CHI and Bio-IT World Present the Thirteenth Annual Structure-Based Drug Design: Genome to Drug Lead with Big Data Approach conference, June 19-21, 2013, Boston, MA, will cover developments in in silico technology, as well as experimental approaches useful

Cambridge Healthtech Institute’s 7th annual G Protein-Coupled Receptor (GPCR) Based Drug Discovery conference will continue its tradition of combining theory with screening and optimization strategies illustrated by case studies of drug candidates in deve

In less than five years next-generation sequencing has gone from radical to routine. Naturally, in a field moving so fast, newbies can feel overwhelmed. Sequencing 101 is designed to provide definitions in terminology, types of platforms, workflow strategies, and current applications, to what's next? Learn about the genomic data revolution from data generation to management to analysis and interpretation. This course is perfect for those needing an introduction to next-generation sequencing technology and applications.

Sub-visible particles present in these biopharmaceutical products are a product quality attribute and a potential patient safety concerns yet to be fully explored. Early and consistent particle detection, quantitation and control throughout the product life cycle of these drugs from development to commercial lot release is critical in mitigating any concerns. This requires appropriate analytical methods which can be applied to biopharmaceuticals across a large variety of protein concentrations and modes of administration. This DVD will cover strategies to utilize complementary methods and techniques at different phases of product development.